Fact CheckerSign in

NCT06124131Completed

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Source: ClinicalTrials.gov · Last updated 4 May 2025

Brief summary (registry, in English)

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
3 Nov 2023
Start date
11 Nov 2023
Primary completion date
25 Mar 2024
Lead sponsor
Tulane University
NCT number
NCT06124131

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 11 Nov 2023 to the primary completion date, 25 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Currently participating in another clinical trial or research study on colorectal cancer screening

Other

  • Unable or unwilling to give informed consent

Who the study is looking for

  • Age 45 to 75
  • Receive care at participating primary care clinic
  • Due for colorectal cancer screening
  • Ability to understand and speak English

Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tulane University School of Medicine
Coordinator of this site? Confirm its status
New OrleansUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.